SCLStepan Company
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−2.7 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.
Trailing-twelve-month operating margin, 0.7% now against 3.4% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is SCL growing?
Stepan Company has grown revenue −1.9% a year over three years and 3.1% a year over five, with earnings per share compounding at −32%.
Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +3.1%
Revenue growth, 5-year rate · −1.9% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −32%
Earnings per share, 3-year rate · revenue −1.9% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $2.35B
- Revenue FY2022
- $2.77B
- Revenue FY2023
- $2.33B
- Revenue FY2024
- $2.18B
- Revenue FY2025
- $2.33B
Annual income statements as filed with the SEC.
Specialty Chemicals
Ranks #27 of 33 by RyuScore